TMS of Knoxville adds the 2-day TMS Treatment
At the 2024 Fall Psychiatric Symposium, international expert on Transcranial Magnetic Stimulation Dr. Jonathan Downar spotlighted groundbreaking developments in transcranial magnetic stimulation (TMS). Among the most discussed was the SAINT protocol (Stanford Accelerated Intelligent Neuromodulation Therapy), which condenses treatment into 10 sessions per day over five days—achieving outcomes equal to or better than the standard […]
Exciting news about accelerated TMS treatment protocols – 5 day and 1 day treatments!
Transcranial Magnetic Stimulation (TMS) for depression is typically administered once a day for 20 minutes, 5 days a week for 6 weeks, followed by a gradual taper over the next 3 weeks. Another alternative is to continue for 7 weeks and 1 day to get all 36 sessions as a study comparing this with […]
Does a popular brain stimulation device work?
The widely advertised Fisher-Wallace device is a transcutaneous alternating current stimulating device. “We conclude that low-frequency tACS at common stimulation intensities neither acutely modulates spindle activity during sleep nor theta activity during waking rest, likely because of the attenuated electrical fields reaching the cortical surface.” To read the article, click here
Treatment-resistant depression in the elderly
Kaiser Health News has a good piece about treatment-resistant depression in the elderly. Nearly 16 million adults have major depression, and up to a third do not respond to treatment. The disease afflicts people of all ages, but experts say that as many as half of older adults don’t get better with standard treatment. Click here to […]
Psychosomatic illness and origins in the brain
www.medscape.com The Biology Behind ‘Psychosomatic’ Illness Bret S. Stetka, MD; Peter L. Strick, PhD|October 07, 2016Introduction Editor’s Note:University of Pittsburgh neuroscientist Peter L. Strick, PhD, and colleagues recently published a study[1] in Proceedings of the National Academy of Sciences tracing the neural circuitry connecting various motor and affective regions of the brain to the adrenal […]
Neuroimaging categorizes 4 depressive subtypes
Researchers discover depression can be categorized into four different subtypes, each defined by different patterns of abnormal brain connectivity.
What’s new in TMS 2021?
It’s been an exciting year with TMS, a few silver linings to an otherwise horrible 2020. Theta burst treatment which we’ve provided for the past 2 years was FDA cleared for the treatment of major depression and can shorten the treatment sessions. When we first started, the Neurostar device was approved and configured to deliver […]
A look at TMS and other new and exciting neuromodulation techniques
(5) NEUROMODULATION BETTER LIVING THROUGH ELECTRONS, PHOTONS AND SOUND WAVES – YouTube I was pleased to present a Continuing Medical Education seminar at the 23rd Annual Fall Psychiatric Symposium on Neuromodulation. It’s fairly scientific, lengthy, and covers TMS. Lane M. Cook, M.D.
FDA Clears accelerated TMS protocol for depression
the SAINT treatment, all TMS sessions delivered in 5 days. Review here: An Inside Look at SAINT Depression Treatment (psychcentral.com)
Novel brain mapping approach finds targets for future clinical trials in depression and Parkinson’s disease
Researchers have made significant advancements in correlating aberrations in specific brain circuits with neuropsychiatric conditions like depression. However, it remains difficult to prove that damage to these circuits causes the symptoms themselves and that targeting them with therapeutics could help patients. By integrating brain lesion datasets with data on how two treatments — deep brain […]
